| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1274 | 2018 |
| TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians G Schoretsanitis, M Paulzen, S Unterecker, M Schwarz, A Conca, ... The world journal of biological psychiatry 19 (3), 162-174, 2018 | 120 | 2018 |
| Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American Society of Clinical Psychopharmacology and the Therapeutic … G Schoretsanitis, JM Kane, CU Correll, SR Marder, L Citrome, ... The Journal of clinical psychiatry 81 (3), 3649, 2020 | 104 | 2020 |
| Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging G Gründer, C Hiemke, M Paulzen, T Veselinovic, I Vernaleken Pharmacopsychiatry 21 (06), 236-248, 2011 | 71 | 2011 |
| Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression T Veselinović, M Paulzen, G Gründer Expert Review of Neurotherapeutics 13 (11), 1141-1159, 2013 | 70 | 2013 |
| Serum concentrations of paliperidone versus risperidone and clinical effects Y Nazirizadeh, F Vogel, W Bader, E Haen, B Pfuhlmann, G Gründer, ... European journal of clinical pharmacology 66, 797-803, 2010 | 66 | 2010 |
| Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [18F] fallypride positron emission tomography study KN Spreckelmeyer, M Paulzen, M Raptis, T Baltus, S Schaffrath, ... Biological psychiatry 70 (8), 770-776, 2011 | 53 | 2011 |
| Antidepressants in breast milk; comparative analysis of excretion ratios G Schoretsanitis, M Augustin, H Saßmannshausen, C Franz, G Gründer, ... Archives of Women's Mental Health 22, 383-390, 2019 | 47 | 2019 |
| Sertraline in pregnancy–Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood M Paulzen, TW Goecke, E Stickeler, G Gründer, G Schoretsanitis Journal of Affective Disorders 212, 1-6, 2017 | 42 | 2017 |
| The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis G Schoretsanitis, O Spigset, JC Stingl, KM Deligiannidis, M Paulzen, ... Expert opinion on drug metabolism & toxicology 16 (5), 431-440, 2020 | 41 | 2020 |
| Toxic psychosis after intake of the hallucinogen salvinorin A M Paulzen, G Gründer The Journal of clinical psychiatry 69 (9), 21103, 2008 | 40 | 2008 |
| Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations M Augustin, G Schoretsanitis, P Pfeifer, G Gründer, C Liebe, M Paulzen Schizophrenia research 210, 143-148, 2019 | 38 | 2019 |
| Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; A pharmacokinetics-based hypothesis M Paulzen, E Haen, B Stegmann, C Hiemke, G Gründer, SE Lammertz, ... Psychoneuroendocrinology 73, 9-15, 2016 | 36 | 2016 |
| Remission of drug-induced hepatitis after switching from risperidone to paliperidone M Paulzen, S Orfanos, G Gründer American Journal of Psychiatry 167 (3), 351-352, 2010 | 36 | 2010 |
| Drug interaction can lead to undetectable serum concentrations of quetiapine in the presence of carbamazepine T Nickl-Jockschat, M Paulzen, F Schneider, M Grözinger Clinical neuropharmacology 32 (1), 55, 2009 | 34 | 2009 |
| Elevated clozapine concentrations in clozapine-treated patients with hypersalivation G Schoretsanitis, M Kuzin, JM Kane, C Hiemke, M Paulzen, E Haen Clinical pharmacokinetics 60, 329-335, 2021 | 31 | 2021 |
| Pharmacokinetic patterns of risperidone-associated adverse drug reactions G Schoretsanitis, B Stegmann, C Hiemke, G Gründer, KRJ Schruers, ... European journal of clinical pharmacology 72, 1091-1098, 2016 | 31 | 2016 |
| Pharmacokinetic drug-drug interactions of mood stabilizers and risperidone in patients under combined treatment G Schoretsanitis, E Haen, G Gründer, B Stegmann, KRJ Schruers, ... Journal of clinical psychopharmacology 36 (6), 554-561, 2016 | 29 | 2016 |
| Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole M Paulzen, G Gründer International Journal of Neuropsychopharmacology 10 (1), 149-151, 2007 | 29 | 2007 |
| Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: a systematic critical review and combined analysis G Schoretsanitis, AA Westin, KM Deligiannidis, O Spigset, M Paulzen Therapeutic drug monitoring 42 (2), 245-254, 2020 | 28 | 2020 |
Gerhard GründerProfessor of Psychiatry, Central Institute of Mental HealthVerified email at zi-mannheim.de
